hematologic malignancy
Conditions
Interventions
Enteral Intervention Group:n-3 PUFA + conventional nutrition
Enteral Placebo:conventional nutrition
Parenteral Intervention group:All-in-one + Fish oil lipid emulsion
Parenteral Placebo:All-in-one
Sponsors
The General Hospital of Western Theater Command
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with hematologic neoplasms; (2) Plan to receive HSCT treatment; (3) Suitable for the measurement of body composition by bioelectrical impedance analysis; (4) Agree to participate in clinical studies and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) suffering from serious cardiovascular and cerebrovascular diseases, liver and kidney diseases, gastrointestinal diseases, endocrine system diseases, infectious diseases or mental disorders; (2) Allergic to intervention capsules or poor compliance; (3) Unable to continue to complete the intervention study or affect the results of the study due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammation parameters;albumin;prealbumin;Retinol binding protein;Bristol score;gut microbiome;Body Composition; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropometry parameters;24h dietary recall; | — |
Countries
China
Contacts
Public ContactChao Kang
The General Hospital of Western Theater Command
Outcome results
None listed